Muggenburg B A, Guilmette R A, Mewhinney J A, Gillett N A, Mauderly J L, Griffith W C, Diel J H, Scott B R, Hahn F F, Boecker B B
Inhalation Toxicology Research Institute, Alburquerque, New Mexico 87185, USA.
Radiat Res. 1996 Mar;145(3):361-81.
This study was conducted to determine the biological effects of inhaled 238PuO2 over the life spans of 144 beagle dogs. The dogs inhaled one of two sizes of monodisperse aerosols of 238PuO2 to achieve graded levels of initial lung burden (ILB). The aerosols also contained 169Yb to provide a gamma-ray-emitting label for the 238Pu inhaled by each dog. Excreta were collected periodically over each dog's life span to estimate plutonium excretion; at death, the tissues were analyzed radiochemically for plutonium activity. The tissue content and the amount of plutonium excreted were used to estimate the ILB. These data for each dog were used in a dosimetry model to estimate tissue doses. The lung, skeleton and liver received the highest alpha-particle doses, ranging from 0.16-68 Gy for the lung, 0.08-8.7 Gy for the skeleton and 0.18-19 for the liver. At death all dogs were necropsied, and all organs and lesions were sampled and examined by histopathology. Findings of non-neoplastic changes included neutropenia and lymphopenia that developed in a dose-related fashion soon after inhalation exposure. These effects persisted for up to 5 years in some animals, but no other health effects could be related to the blood changes observed. Radiation pneumonitis was observed among the dogs with the highest ILBs. Deaths from radiation pneumonitis occurred from 1.5 to 5.4 years after exposure. Tumors of the lung, skeleton and liver occurred beginning at about 3 years after exposure. Bone tumors found in 93 dogs were the most common cause of death. Lung tumors found in 46 dogs were the second most common cause of death. Liver tumors, which were found in 20 dogs but were the cause of death in only two dogs, occurred later than the tumors in bone and lung. Tumors in these three organs often occurred in the same animal and were competing causes of death. These findings in dogs suggest that similar dose-related biological effects could be expected in humans accidentally exposed to 238PuO2.
本研究旨在确定吸入238PuO2对144只比格犬寿命期间的生物学效应。这些犬吸入两种大小单分散的238PuO2气溶胶之一,以达到不同水平的初始肺负荷(ILB)。气溶胶中还含有169Yb,为每只犬吸入的238Pu提供一个发射伽马射线的标记。在每只犬的寿命期间定期收集排泄物,以估计钚的排泄量;在犬死亡时,对组织进行放射化学分析以测定钚活性。组织中的钚含量和排泄的钚量用于估计初始肺负荷。每只犬的这些数据用于剂量测定模型以估计组织剂量。肺、骨骼和肝脏接受的α粒子剂量最高,肺的剂量范围为0.16 - 68 Gy,骨骼为0.08 - 8.7 Gy,肝脏为0.18 - 19 Gy。犬死亡时全部进行尸检,所有器官和病变均取样并进行组织病理学检查。非肿瘤性变化的发现包括吸入暴露后不久以剂量相关方式出现的中性粒细胞减少和淋巴细胞减少。这些效应在一些动物中持续长达5年,但未观察到其他与血液变化相关的健康影响。在初始肺负荷最高的犬中观察到放射性肺炎。放射性肺炎导致的死亡发生在暴露后1.5至5.4年。肺、骨骼和肝脏的肿瘤在暴露后约3年开始出现。93只犬中发现的骨肿瘤是最常见的死亡原因。46只犬中发现的肺肿瘤是第二常见的死亡原因。20只犬中发现的肝肿瘤发生时间晚于骨和肺的肿瘤,仅两只犬因肝肿瘤死亡。这三种器官的肿瘤常发生在同一只动物身上,是相互竞争的死亡原因。犬的这些发现表明,意外暴露于238PuO2的人类可能会出现类似的剂量相关生物学效应。